Related Experiment Video
Updated: Jul 8, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Influence of vascular access type on outcome measures in patients on maintenance hemodialysis
Deepa H Chand1, Boon Wee Teo, Richard A Fatica
1Department of Pediatric Nephrology and Hypertension, Akron Children's Hospital, Akron, Ohio 44308, USA. dchand@chmca.org
Insights
Patients on hemodialysis using central venous catheters (CVC) show poorer outcomes than those with arteriovenous fistulae (AVF) or grafts (AVG). This highlights the need to prioritize AVF or adjust CVC care for better results in end-stage renal disease (ESRD) patients.
Area of Science:
- Nephrology
- Vascular Access
- Renal Replacement Therapy
Background:
- End-stage renal disease (ESRD) patients often require hemodialysis.
- Vascular access type (arteriovenous fistula (AVF), arteriovenous graft (AVG), or central venous catheter (CVC)) significantly impacts patient outcomes.
- Previous studies suggest poorer outcomes for patients using CVC compared to AVF or AVG.
Purpose of the Study:
- To compare clinical measures of dialysis adequacy, anemia management, and nutritional/inflammatory status among prevalent hemodialysis patients based on vascular access type.
- To determine if current clinical practice guidelines adequately address potential outcome disparities related to vascular access.
Main Methods:
- Analysis of data from The Renal Network Data System for 12,501 prevalent hemodialysis patients in 2003.
- Univariate analysis of variance used to compare Kt/V, Urea Reduction Ratio (URR), albumin, hemoglobin (Hb), and recombinant human erythropoietin (EPO) dose across access types (AVF, AVG, CVC).
- Statistical adjustments made for pertinent confounding factors.
Main Results:
- Central venous catheter (CVC) use was observed in 23% of patients, contrasted with 36% for AVF and 41% for AVG.
- Patients dialyzed via CVC demonstrated significantly lower mean URR, Kt/V, and albumin concentrations (p < 0.001) compared to AVF and AVG users.
- While serum hemoglobin levels were similar across groups (p = 0.416), CVC patients required higher doses of EPO (p < 0.001).
Conclusions:
- Despite established practice guidelines, hemodialysis patients utilizing CVC exhibit inferior clinical outcomes compared to those with AVF or AVG.
- Findings underscore the importance of prioritizing AVF use or implementing appropriate adjustments for CVC patients to achieve comparable outcomes.
- Further research is recommended to identify and address the barriers contributing to these disparities in CVC patient care.
Background:
Previous studies postulate that end-stage renal disease (ESRD) patients dialyzed with central venous catheters (CVC) have poorer outcomes compared to patients using arteriovenous fistulae (AVF) or arteriovenous grafts (AVG). Clinical practice guidelines should obviate these differences if access was not important. This study compared clinical measures of adequacy, anemia, and nutrition/inflammation in prevalent hemodialysis patients in 2003 by access type.
Methods:
Data from The Renal Network Data System were analyzed by univariate analysis of variance to compare Kt/V, URR, albumin, hemoglobin (Hb) and recombinant human erythropoietin (EPO) dose by access type, while adjusting for pertinent factors.
Results:
12,501 patients were included. The access type distribution was AVF 36%, AVG 41%, and CVC 23%. CVC patients had lower mean URR, Kt/V, albumin concentration (p < 0.001) than other accesses. Serum Hbs were similar (p = 0.416), however EPO dose (U/kg/week) was higher in those dialyzed with CVC compared to AVF/AVG (p < 0.001).
Conclusions:
Despite practice guidelines, patients dialyzed via CVC have poorer outcome measures compared to other accesses. This suggests that AVF should be used and/or appropriate adjustments need to be made for those dialyzed with CVC to achieve equal outcomes. Further studies defining barriers need to be conducted.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Continuous Renal Replacement Therapy
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management